Harshi Gangrade

I am Harshi Gangrade, a senior research associate at CRISPR Therapeutics. My focus is on manipulating the expression of the Angiotensinogen gene to manage refractory hypertension. Originally from India, I completed my Bachelor’s in Biotechnology at D.Y. Patil University before pursuing my Masters in Biotechnology at Johns Hopkins University in the United States, graduating in 2020. Following my studies, I conducted research under Dr. Emmanouil Tampakakis in a cardiology lab at Johns Hopkins Medical Institute, where I contributed to several projects and authored multiple research papers. After two years, I transitioned to industrial research to gain insights into the commercial aspects and the translation of biotechnology from laboratory experiments to practical applications. Joining CRISPR Therapeutics in 2022 has provided me with valuable opportunities in this regard, and I have found great satisfaction in my work here ever since.